379 related articles for article (PubMed ID: 11494125)
61. Syk deficiency--a knockout for B-cell development.
Harnett M
Immunol Today; 1996 Jan; 17(1):4. PubMed ID: 8652052
[No Abstract] [Full Text] [Related]
62. [Expression of tyrosine kinase Syk in breast cancer and their clinical significance].
Ding YB; Wu ZY; Wang S; Fan P; Zha XM; Zheng W; Liu XA
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):137-9. PubMed ID: 15062056
[TBL] [Abstract][Full Text] [Related]
63. The role of the Syk/Shp-1 kinase-phosphatase equilibrium in B cell development and signaling.
Alsadeq A; Hobeika E; Medgyesi D; Kläsener K; Reth M
J Immunol; 2014 Jul; 193(1):268-76. PubMed ID: 24899508
[TBL] [Abstract][Full Text] [Related]
64. Constitutive kinase activation of the TEL-Syk fusion gene in myelodysplastic syndrome with t(9;12)(q22;p12).
Kuno Y; Abe A; Emi N; Iida M; Yokozawa T; Towatari M; Tanimoto M; Saito H
Blood; 2001 Feb; 97(4):1050-5. PubMed ID: 11159536
[TBL] [Abstract][Full Text] [Related]
65. Differential intrinsic enzymatic activity of Syk and Zap-70 protein-tyrosine kinases.
Latour S; Chow LM; Veillette A
J Biol Chem; 1996 Sep; 271(37):22782-90. PubMed ID: 8798454
[TBL] [Abstract][Full Text] [Related]
66. Gene expression of the hematopoietic cell phosphatase in juvenile myelomonocytic leukemia.
Wütz D; Shayan P; Schmahl GE; Mild GC; Feil B; Röll S; Kontny HU; Niemeyer CM
Leuk Lymphoma; 1999 Nov; 35(5-6):491-9. PubMed ID: 10609786
[TBL] [Abstract][Full Text] [Related]
67. Disruption of epithelial gamma delta T cell repertoires by mutation of the Syk tyrosine kinase.
Mallick-Wood CA; Pao W; Cheng AM; Lewis JM; Kulkarni S; Bolen JB; Rowley B; Tigelaar RE; Pawson T; Hayday AC
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9704-9. PubMed ID: 8790395
[TBL] [Abstract][Full Text] [Related]
68. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
[TBL] [Abstract][Full Text] [Related]
69. Syk protein-tyrosine kinase is involved in neuron-like differentiation of embryonal carcinoma P19 cells.
Tsujimura T; Yanagi S; Inatome R; Takano T; Ishihara I; Mitsui N; Takahashi S; Yamamura H
FEBS Lett; 2001 Feb; 489(2-3):129-33. PubMed ID: 11165236
[TBL] [Abstract][Full Text] [Related]
70. Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Lymphoma; 1999 Nov; 35(5-6):513-26. PubMed ID: 10609789
[TBL] [Abstract][Full Text] [Related]
71. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
[TBL] [Abstract][Full Text] [Related]
72. Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora.
Duta F; Ulanova M; Seidel D; Puttagunta L; Musat-Marcu S; Harrod KS; Schreiber AD; Steinhoff U; Befus AD
Histochem Cell Biol; 2006 Oct; 126(4):495-505. PubMed ID: 16708245
[TBL] [Abstract][Full Text] [Related]
73. Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Uckun FM; Downing JR; Gunther R; Chelstrom LM; Finnegan D; Land VJ; Borowitz MJ; Carroll AJ; Crist WM
Blood; 1993 Jun; 81(11):3052-62. PubMed ID: 8098968
[TBL] [Abstract][Full Text] [Related]
74. Abnormal splicing of SHP-1 protein tyrosine phosphatase in human T cells. Implications for lymphomagenesis.
Ma XZ; Jin T; Sakac D; Fahim S; Zhang X; Katsman Y; Bali M; Branch DR
Exp Hematol; 2003 Feb; 31(2):131-42. PubMed ID: 12591278
[TBL] [Abstract][Full Text] [Related]
75. Syk mutation in Jurkat E6-derived clones results in lack of p72syk expression.
Fargnoli J; Burkhardt AL; Laverty M; Kut SA; van Oers NS; Weiss A; Bolen JB
J Biol Chem; 1995 Nov; 270(44):26533-7. PubMed ID: 7592872
[TBL] [Abstract][Full Text] [Related]
76. Syk deficiency in nonreleaser basophils.
Kepley CL; Youssef L; Andrews RP; Wilson BS; Oliver JM
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):279-84. PubMed ID: 10452745
[TBL] [Abstract][Full Text] [Related]
77. Liposomal Nanoparticles of a Spleen Tyrosine Kinase P-Site Inhibitor Amplify the Potency of Low Dose Total Body Irradiation Against Aggressive B-Precursor Leukemia and Yield Superior Survival Outcomes in Mice.
Uckun FM; Myers DE; Cheng J; Qazi S
EBioMedicine; 2015 Jun; 2(6):554-62. PubMed ID: 26285772
[TBL] [Abstract][Full Text] [Related]
78. Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice.
Yanagi S; Inatome R; Ding J; Kitaguchi H; Tybulewicz VL; Yamamura H
Blood; 2001 Nov; 98(9):2869-71. PubMed ID: 11675365
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
Firtina S; Sayitoglu M; Hatirnaz O; Erbilgin Y; Oztunc C; Cinar S; Yildiz I; Celkan T; Anak S; Unuvar A; Devecioglu O; Timur C; Aydogan G; Akcay A; Atay D; Turkkan E; Karaman S; Orhaner B; Sarper N; Deniz G; Ozbek U
Leuk Res; 2012 Jan; 36(1):87-92. PubMed ID: 21813177
[TBL] [Abstract][Full Text] [Related]
80. Reduced expression of the Syk gene is correlated with poor prognosis in human breast cancer.
Toyama T; Iwase H; Yamashita H; Hara Y; Omoto Y; Sugiura H; Zhang Z; Fujii Y
Cancer Lett; 2003 Jan; 189(1):97-102. PubMed ID: 12445683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
